Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Astral Limited - On a strong footing; top pick in pipes - ICICI Securities

Posted On: 2021-04-15 04:59:35 (Time Zone: UTC)

We upgrade ASTRA to BUY with the stock correcting ~27% in the last one month. Besides expecting the company to continue with its strong earnings traction post Covid, we expect its premium valuations to sustain driven by a) sustained market share gain opportunity in piping segment with likely accelerated consolidation in PVC/CPVC pipes segment in the post Covid environment; b) strong option value in its adhesive business (capable of growing at 20-25% CAGR over the next 3-5 years); c) strong growth opportunity in tanks (likely to achieve Rs1.5bn revenue by FY23) and DWC pipe (expected to post 25-30% CAGR over next 2-3 years) segments; c) expansion of manufacturing footprint (Odisha plant to commence by Oct'21) which opens up huge opportunity in East India (where its scale is currently at ~1/10th of Supreme's revenue in East India); d) option value in the form of likely acquisition/(s) (with ASTRA likely to close FY23 with cash on books in excess of Rs10bn) and e) pre-tax RoCEs (ex-cash) likely to touch 50% by FY23.

- Valuation and outlook: Considering the robust growth outlook amid the ongoing second Covid wave, we increase our revenue and PAT estimates by 4.4%/8.3%/8.1% and 6.7%/7.2%/7.9% for FY21E/FY22E/FY23E, respectively. We expect ASTRA to report overall revenue/PAT CAGR of 23.1%/39.1%, respectively, over FY20-FY23E. We upgrade ASTRA to BUY (from HOLD) with a revised target price of Rs1,663 (earlier: Rs1,387), implying a P/E multiple of 50x (earlier - 45x) FY23E earnings. Key risks: 1) Sharp decline in PVC prices and 2) lower than expected pick-up in adhesive business.

- Prefer ASTRA (post recent correction) over Prince Pipes (PPF) and Supreme Industries (SI): We expect ASTRA's earnings to outpace its key peers in FY22 driven by 1) likely least impact of the recent strict restrictions imposed by few states amid the ongoing second Covid wave with Q1 revenue being much leaner at 17-18% of overall sales for ASTRA vs 24-25% for SI and 21-22% for PPF; 2) likely least impact on its realisations and margins on account of expected steep price fall in PVC pipes segment post Q1FY22 with expected uptick in CPVC pipes prices (by ~15-20%) in FY22E (ASTRA's share in CPVC pipes segment being significantly higher than peers; Q1FY22 has already seen a price hike of 6-8% in CPVC pipes) and 3) its least impact of muted growth in agricultural pipes segment (due to elevated prices of agricultural PVC pipes in Q1FY22 - being a key season) where ASTRA's share is least at 4-5% vs SI at ~30-35% and PPF at ~30%.

- RoCEs (adjusted for cash) likely to touch 50% by FY23E. Strong earnings momentum, stricter working capital management and impressive free cash generation (due to muted capex) are expected to drive significant cash on books (Rs10bn+) by FY23E. We thus assign a 50 PE multiple to ASTRA's FY23 earnings compared to 35x for SI and 25x for PPF considering a) its high RoCE (adj. for cash) profile (50.6% for ASTRA vs 28.3% for SI and 27.1% for PPF) and b) option value in the form of likely acquisitions and its scaling up of its niche segments (adhesives, tanks and DWC pipes).

Shares of ASTRAL LTD. was last trading in BSE at Rs.1516.5 as compared to the previous close of Rs. 1597.25. The total number of shares traded during the day was 36957 in over 6912 trades.

The stock hit an intraday high of Rs. 1578 and intraday low of 1500. The net turnover during the day was Rs. 56357715.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Dabur India: REDUCE - Q4FY21 Result Update - YES Securities

Maintain BUY on CreditAccess Grameen - Accelerated write-offs dents earnings - HDFC Securities

Sundram Fasteners Q4 Results Review - HDFC Securities

SRF - Specialty Chemicals continues to shine! - HDFC Securities

Realtors welcome RBI latest stance, expect relief initiatives in next announcement

CreditAccess Grameen - Q4FY21 Result Update - ICICI Securities

JM Financial - Exits FY21 with well contained stress pool; sequential AUM uptick encouraging - ICICI Securities

Hero MotoCorp - Margins remain resilient - ICICI Securities

CEAT - Margin pressures likely to intensify - ICICI Securities

SRF Limited - FY22E growth capped on higher plants utilisation - ICICI Securities

I-direct Instinct - Automotive Axles - ICICI Direct

Quant Pick - Axis Bank - ICICI Direct

Gladiator Stocks - Caplin Point Laboratories - ICICI Direct

Q4FY21 Result Update - Coforge Ltd - ICICI Direct

Tata Consumer Products - Q4FY21 First Cut - ICICI Direct

Coforge Ltd - Q4FY21 Result Update - YES Securities

CreditAccess Grameen - Q4FY21 Result Update - YES Securities

Blue Star - Q4 FY21 first cut - Inline performance - YES Securities

Tata Consumer - 4QFY21 results first cut - YES Securities

Tata Consumer 4QFY21 results first cut - YES Securities

Maintain BUY on CDSL - Strong growth momentum - HDFC Securities

Maintain ADD on L&T Infotech - Steady progression - HDFC Securities

Blue Dart Express - Q4FY21 - The bulge continues - ICICI Securities

Tata Steel - FY22E Net Debt/EBITDA at <1x - ICICI Securities

Larsen & Toubro Infotech - Consistency continues! - ICICI Securities

CEAT - Decent quarter; new capex likely to curtail FCF - ICICI Securities

Q4FY21 Result Update - Alembic Pharma - ICICI Direct

Gladiator Stocks - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro Infotech - ICICI Direct

RBI Action Update - May 2021 - ICICI Direct

Quant Pick - Aurobindo Pharma - ICICI Direct

Q4FY21 Result Update - Greaves Cotton - ICICI Direct

Adani Total Gas Ltd - Q4FY21 Result Update - YES Securities

L&T Infotech - Q4FY21 Result Update - YES Securities

Bluedart Express - Q4 FY21 first cut - Miss on topline; Profitability improves - YES Securities

Views on the announcement by RBI Governor - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Views from experts on RBI announcement - May 5, 2021

Maintain REDUCE on RBL Bank - Elevated retail slippages continue - HDFC Securities

Resolution 2.0 measure by RBI to provide relief to real estate linked SME stakeholders

Godrej Properties - Robust quarter; positives fairly priced in - HDFC Securities

RBI Relief 2.0 - May 2021 - Acuité Ratings & Research

MDF Industry - Countervailing duty on MDF recommended; imports may get hit structurally - ICICI Securities

Home First Finance Company - Core earnings steady; profitability buoyed by securitisation income - ICICI Securities

RBL Bank - Modest return profile in the interim; transitioning underway - ICICI Securities

Alembic Pharmaceuticals - US continues to be under pressure - ICICI Securities

Q4FY21 Result Update - SBI Life Insurance - ICICI Direct

Q1CY21 Result Update - Varun Beverages - ICICI Direct

RBL Bank: Views from leading research houses on Q4FY21 results

Q4FY21 Result Update - Supreme Industries - ICICI Direct

Q4FY21 Result Update - Tata Chemicals - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020